ADCC and treatment outcome in colorectal cancer patients receiving cetuximab-based therapy.

e15085Background: ADCC (Antibody Dependent Cell Cytotoxicity) is a complement of antitumor activity, mainly mediated by the presence of FC receptor on tumor infiltrated NK cells and conferred by Ig...